intends to bridge the gap between basic university research and clinical pharmaceutical companies, especially by offerning a perfect academic environment for proof of concept studies. The company is a spin-off from the IPA – Department of Pathophysiology and Allergy Research of the Medical University Vienna, with a tradition of excellency in science, especially in the fields allergology and immunology. The pole position at the General Hospital allows the IPA tight interactions with clinical departments and translational studies.